Tickerplace logo

Tickerplace

Cognition Therapeutics, Inc. logo

CGTXCognition Therapeutics, Inc.

CGTX Stock Price, Valuation & Chart | Cognition Therapeutics, Inc.

Compare
$1.050+0.04 (+3.96%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyCGTX intrinsic valueCGTX calculated fair value vs price
OverviewFinancialsDividendsRatios

CGTX Historical price chart

CGTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization93.97M
PE Ratio-4.37
EPS-0.24
Trading Volume376.89K
Today's High/Low1.07/1.0
Dividend Yield0.00
52 Week High/Low2.67/0.55
Shares Outstanding89.50M
CGTX Financial Statement
CGTX Analyst ratings
CGTX Analysis & performance metrics

CGTX Company profile

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related…

CGTX Management team

Management
Anita Cornet
Head of Quality
Steven A. Weissman Ph.D.
Vice President & Head of CMC
John Brendan DoyleCFO
Chief Financial Officer
Lisa RicciardiCEO
Chief Executive Officer, President & Director
Anthony O. Caggiano M.D., Ph.D.
Chief Medical Officer and Head of R&D
Bobby Horn
Corporate Controller
Total 6 executives

CGTX Frequently asked questions

What is Cognition Therapeutics, Inc. (CGTX) Stock Price?

Current stock price of Cognition Therapeutics, Inc. (CGTX) stock is $1.050. The stock price is +3.96% higher in the session. The intraday range can be seen from this page. Volume of Cognition Therapeutics, Inc. (CGTX) stock is 376.89K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Cognition Therapeutics, Inc. (CGTX) stock price going up or down today?

The stock price of Cognition Therapeutics, Inc. (CGTX) can change with earnings, company news, and overall market sentiment. Cognition Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cognition Therapeutics, Inc. stock expensive at its current price?

Whether Cognition Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CGTX on this page is -4.37. EPS on this page is -0.24. Compare those figures with peers and growth expectations before deciding if the current Cognition Therapeutics, Inc. price is justified.

How has the stock price of Cognition Therapeutics, Inc. (CGTX) performed historically?

Historical performance for Cognition Therapeutics, Inc. (CGTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CGTX reacted to past earnings and market events.

Should I buy Cognition Therapeutics, Inc. (CGTX) stock, at this price?

Buying Cognition Therapeutics, Inc. (CGTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.